← Back to Search

Insulin Bolus Calculator

A Continuous Glucose Monitor Based Insulin Bolus Calculator (CGM-IBC) Study B

N/A
Waitlist Available
Led By Jean Park
Research Sponsored by Welldoc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial tests the safety of an app that helps people with diabetes decide their insulin dose using real-time blood sugar data. It targets individuals with type 1 or type 2 diabetes who need to calculate their insulin for meals. App-based insulin calculators are promising tools to help people with diabetes administer insulin safely and have potential to improve blood sugar control.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: CGM insulin bolus calculator armExperimental Treatment1 Intervention
Participants will use the CGM insulin bolus calculator arm
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BlueStar 10
2022
N/A
~30

Find a Location

Who is running the clinical trial?

WelldocLead Sponsor
1 Previous Clinical Trials
27 Total Patients Enrolled
Jean ParkPrincipal InvestigatorMedstar Health Research Institute
~8 spots leftby Dec 2025